a public good project by the
Synthesis
Company
of California

© 2026

Helmut Gadner | doi.page

0 works0 citations0 h-index

Helmut Gadner

Publications by Year

Research Areas

Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Childhood Cancer Survivors' Quality of Life, Histiocytic Disorders and Treatments

Most-Cited Works

→ Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group(2000)1,044 cited
→ Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols(2003)943 cited
→ Contemporary classification of histiocytic disorders(1997)836 cited
→ Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol(2011)671 cited
→ MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration(1991)655 cited
→ Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

(2000)

609 cited

→ Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95(2008)607 cited

→ Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995(2000)529 cited

→ HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis(1997)529 cited

→ Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000(2009)521 cited